SCM
COLL icon

Stonepine Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Stonepine Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-41,500
Closed -$1.23M – 64
2025
Q2 		$1.23M Buy
41,500
+20,893
+101% +$596K 1.2% 22
2025
Q1 		$615K Buy
+20,607
New +$630K 0.6% 34
2019
Q2 		– Sell
-60,045
Closed -$909K – 26
2019
Q1 		$909K Buy
+60,045
New +$962K 0.52% 30

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Stonepine Capital Management's COLL Position: Q3 2025 in Review

Stonepine Capital Management sold out of Collegium Pharmaceutical (COLL) in Q3 2025, closing a stake of 41,500 shares — an estimated $1.23M sold.

Stonepine Capital Management first reported a position in COLL in Q1 2019 and held it in 3 quarters. The position peaked at $1.23M in Q2 2025. 244 funds tracked by Wall St. Rank hold COLL as of Q3 2025.

  • Stonepine Capital Management reported no remaining Collegium Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Stonepine Capital Management sold 41,500 Collegium Pharmaceutical shares in Q3 2025, an estimated $1.23M.
  • Stonepine Capital Management first reported a position in Collegium Pharmaceutical in Q1 2019 and held it in 3 quarters.
  • Stonepine Capital Management's Collegium Pharmaceutical position peaked at $1.23M in Q2 2025.
  • 244 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2025.

Based on Stonepine Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.